These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26483779)

  • 1. NK cell function and receptor diversity in the context of HCV infection.
    Gardiner CM
    Front Microbiol; 2015; 6():1061. PubMed ID: 26483779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.
    Manickam C; Rajakumar P; Wachtman L; Kramer JA; Martinot AJ; Varner V; Giavedoni LD; Reeves RK
    J Virol; 2016 Oct; 90(20):9153-62. PubMed ID: 27489267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.
    Goh CC; Roggerson KM; Lee HC; Golden-Mason L; Rosen HR; Hahn YS
    J Immunol; 2016 Mar; 196(5):2283-92. PubMed ID: 26826241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection.
    Njiomegnie GF; Read SA; Fewings N; George J; McKay F; Ahlenstiel G
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells in hepatitis C: Current progress.
    Yoon JC; Yang CM; Song Y; Lee JM
    World J Gastroenterol; 2016 Jan; 22(4):1449-60. PubMed ID: 26819513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.
    Yang CM; Yoon JC; Park JH; Lee JM
    PLoS One; 2017; 12(4):e0175793. PubMed ID: 28410411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell function and dysfunction in hepatitis C virus infection.
    Holder KA; Russell RS; Grant MD
    Biomed Res Int; 2014; 2014():903764. PubMed ID: 25057504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.
    Chigbu DI; Loonawat R; Sehgal M; Patel D; Jain P
    Cells; 2019 Apr; 8(4):. PubMed ID: 31027278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?
    Mondelli MU; Oliviero B; Mele D; Mantovani S; Gazzabin C; Varchetta S
    Front Immunol; 2012; 3():351. PubMed ID: 23420385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection.
    Irshad M; Gupta P; Irshad K
    Viral Immunol; 2019 Apr; 32(3):112-120. PubMed ID: 30817236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.
    Ahmad A; Alvarez F
    J Leukoc Biol; 2004 Oct; 76(4):743-59. PubMed ID: 15218054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
    Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
    Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
    Golden-Mason L; Rosen HR
    Liver Transpl; 2006 Mar; 12(3):363-72. PubMed ID: 16498647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immunity in hepatitis C virus infection: Interplay among dendritic cells, natural killer cells and natural killer T cells.
    Kanto T; Hayashi N
    Hepatol Res; 2007 Oct; 37 Suppl 3():S319-26. PubMed ID: 17931181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cells.
    Goeser F; Glässner A; Kokordelis P; Wolter F; Lutz P; Kaczmarek DJ; Schwarze-Zander C; Boesecke C; Strassburg CP; Rockstroh JK; Spengler U; Krämer B; Nattermann J
    AIDS; 2016 Jan; 30(3):355-63. PubMed ID: 26558728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells in hepatitis C: role in disease susceptibility and therapy.
    Lunemann S; Schlaphoff V; Cornberg M; Wedemeyer H
    Dig Dis; 2012; 30 Suppl 1():48-54. PubMed ID: 23075868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
    Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
    Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.